Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 11/2017

01-10-2017 | Reconstructive Oncology

Implications of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) for Breast Cancer Reconstruction: An Update for Surgical Oncologists

Authors: Anne C. O’Neill, MBBCh, PhD, Toni Zhong, MD, MHS, Stefan O. P. Hofer, MD, PhD

Published in: Annals of Surgical Oncology | Issue 11/2017

Login to get access

Abstract

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare disease that has been diagnosed in an extremely small proportion of women with breast implants. The pathogenesis of this disease is currently poorly understood, but it appears to be related to textured implants. Recent high-profile media coverage of this rare clinical entity is likely to cause considerable anxiety for breast cancer patients who have undergone alloplastic breast reconstruction. The purpose of this review is to provide surgical oncologists with an evidence-based overview of the incidence, diagnosis, and management of BIA-ALCL with a particular emphasis on breast reconstruction cases. It is essential that surgical oncologists are familiar with BIA-ALCL, because although it is extremely rare, early recognition and surgical resection will be curative in many cases.
Literature
1.
Platt J, Baxter N, Zhong T. Breast reconstruction after mastectomy for breast cancer. CMAJ Can Med Assoc J. 2011;183:2109–16.CrossRef
2.
Zhong T, Hu J, Bagher S, et al. A comparison of psychological response, body image, sexuality, and quality of life between immediate and delayed autologous tissue breast reconstruction: a prospective long-term outcome study. Plast Reconstr Surg. 2016;138:772–80.CrossRefPubMed
3.
Zhong T, McCarthy C, Min S, et al. Patient satisfaction and health-related quality of life after autologous tissue breast reconstruction: a prospective analysis of early postoperative outcomes. Cancer. 2012;118:1701–9.CrossRefPubMed
4.
Chao AH, Garza R III, Povoski SP. A review of the use of silicone implants in breast surgery. Exp Rev Med Dev. 2016;13:143–56.CrossRef
5.
Albornoz CR, Bach PB, Mehrara BJ, et al. A paradigm shift in U.S. Breast reconstruction: increasing implant rates. Plast Reconstr Surg. 2013;131:15–23.CrossRefPubMed
6.
Aladily TN, Medeiros LJ, Amin MB, et al. Anaplastic large cell lymphoma associated with breast implants: a report of 13 cases. Am J Surg Pathol. 2012;36:1000–8.CrossRefPubMed
7.
Clemens MW, Miranda RN. Coming of age: breast implant-associated anaplastic large cell lymphoma after 18 years of investigation. Clin Plast Surg. 2015;42:605–13.CrossRefPubMed
8.
Gidengil CA, Predmore Z, Mattke S, van Busum K, Kim B. Breast implant-associated anaplastic large cell lymphoma: a systematic review. Plast Reconstr Surg. 2015;135:713–20.CrossRefPubMed
9.
Jewell M, Spear SL, Largent J, Oefelein MG, Adams WP Jr. Anaplastic large T-cell lymphoma and breast implants: a review of the literature. Plast Reconstr Surg. 2011;128:651–61.CrossRefPubMed
10.
Rupani A, Frame JD, Kamel D. Lymphomas associated with breast implants: a review of the literature. Aesthet Surg J. 2015;35:533–44.CrossRef
11.
Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin’s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985;66:848–58.PubMed
12.
Jacobsen E. Anaplastic large-cell lymphoma, T-/null-cell type. Oncologist. 2006;11:831–40.PubMed
13.
Keech JA Jr, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg. 1997;100:554–5.CrossRefPubMed
14.
de Jong D, Vasmel WL, de Boer JP, et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA. 2008;300:2030–5.CrossRefPubMed
15.
Validire P, Capovilla M, Asselain B, et al. Primary breast non-Hodgkin’s lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors. Am J Hematol. 2009;84:133–9.CrossRefPubMed
16.
George EV, Pharm J, Houston C, et al. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis. Int J Clin Exp Oathol. 2013;6:1631–42.
17.
Brody GS, Deapen D, Taylor CR, et al. Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases. Plast Reconstr Surg. 2015;135:695–705.CrossRefPubMed
18.
Doren EL, Miranda RN, Selber JC, et al. U.S. epidemiology of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg. 2017;139:1042–50.CrossRefPubMed
19.
Clemens MW, Nava MB, Rocco N, Miranda RN. Understanding rare adverse sequelae of breast implants: anaplastic large-cell lymphoma, late seromas, and double capsules. Gland Surg. 2017;6:169–84.CrossRefPubMedPubMedCentral
20.
Miranda RN, Aladily TN, Prince HM, et al. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol. 2014;32:114–20.CrossRefPubMed
21.
Adrada BE, Miranda RN, Rauch GM, et al. Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients. Breast Cancer Res Treat. 2014;147:1–14.CrossRefPubMed
22.
Clemens MW and Horwitz SM. NCCN consensus guidelines for the diagnosis and management of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J. 2017;37:285–9.CrossRef
23.
Taylor CR, Siddiqi IN, Brody GS. Anaplastic large cell lymphoma occurring in association with breast implants: review of pathologic and immunohistochemical features in 103 cases. Appl Immunohistochem Mol Morphol. 2013;21:13–20.PubMed
24.
Loch-Wilkinson A, Beath K, Knight RJW, et al. Breast implant-associated Anaplastic Large Cell Lymphoma in Australia and New Zealand: high surface area textured implants are associated with increased risk. Plast Reconstr Surg. 2017. doi:10.​1097/​PRS.​0000000000003654​ PubMed
25.
Clemens MW, Medeiros LJ, Butler CE, et al. Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma. J Clin Oncol. 2016;34:160–8.CrossRefPubMed
26.
Hart AM, Lechowicz MJ, Peters KK, Holden J, Carlson GW. Breast implant-associated anaplastic large cell lymphoma: report of 2 cases and review of the literature. Aesthet Surg J. 2014;34:884–94.CrossRef
27.
Roden AC, Macon WR, Keeney GL, Myers JL, Feldman AL, Dogan A. Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol. 2008;21:455–63.CrossRefPubMed
28.
Loeser E. Long-term toxicity and carcinogenicity studies with 2,4/2,6-toluene-diisocyanate (80/20) in rats and mice. Toxicol Lett. 1983;15:71–81.CrossRefPubMed
29.
Ferreri AJ, Govi S, Pileri SA, Savage KJ. Anaplastic large cell lymphoma, ALK-negative. Crit Rev Oncol Hematol. 2013;85:206–15.CrossRefPubMed
30.
Kadin ME, Deva A, Xu H, et al. Biomarkers provide clues to early events in the pathogenesis of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J. 2016;36:773–81.CrossRef
31.
Digby JM. Malignant lymphoma with intranodal silicone rubber particles following metacarpophalangeal joint replacements. Hand. 1982;14:326–8.CrossRefPubMed
32.
Murakata LA, Rangwala AF. Silicone lymphadenopathy with concomitant malignant lymphoma. J Rheumatol. 1989;16:1480–3.PubMed
33.
Weathers WM, Wolfswinkel EM, Hatef DA, Lee EI, Hollier LH, Brown RH. Implant-associated anaplastic large cell lymphoma of the breast: insight into a poorly understood disease. Can J Plast Surg. 2013;21:95–8.CrossRefPubMedPubMedCentral
34.
Hu H, Johani K, Almatroudi A, et al. Bacterial biofilm infection detected in breast implant-associated anaplastic large-cell lymphoma. Plast Reconstr Surg. 2016;137:1659–69.CrossRefPubMed
35.
Blombery P, Thompson ER, Jones K, et al. Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma. Haematologica. 2016;101:e387–90.CrossRefPubMedPubMedCentral
36.
Lechner MG, Lade S, Liebertz DJ, et al. Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity. Cancer. 2011;117:1478–89.CrossRefPubMed
37.
Unger JG, Carreras JM, Nagarkar P, Jeong HS, Carpenter W. Allergan style 410 implants for breast reconstruction: a prospective study in efficacy, safety, and symmetry. Plast Reconstr Surg. 2016;138:548–55.CrossRefPubMed
38.
Clemens MW, Miranda RN, Butler CE. Breast Implant informed consent should include the risk of anaplastic large cell lymphoma. Plast Reconstr Surg. 2016;137:1117–22.CrossRefPubMed
Metadata
Title
Implications of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) for Breast Cancer Reconstruction: An Update for Surgical Oncologists
Authors
Anne C. O’Neill, MBBCh, PhD
Toni Zhong, MD, MHS
Stefan O. P. Hofer, MD, PhD
Publication date
01-10-2017
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 11/2017
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-6014-0

Other articles of this Issue 11/2017

Annals of Surgical Oncology 11/2017 Go to the issue

Endocrine Tumors

Sustained Growth of a University-Based Endocrine Surgery Program Over 10 Years

Endocrine Tumors

Patients with Non-invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features are Unlikely to have Malignant Preoperative Cytology

Translational Research and Biomarkers

FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer

Breast Oncology

The Impact of Facility Volume on Rates of Pathologic Complete Response to Neoadjuvant Chemotherapy Used in Breast Cancer

Gastrointestinal Oncology

“Pancreas-Compressionless Gastrectomy”: A Novel Laparoscopic Approach for Suprapancreatic Lymph Node Dissection

Urologic Oncology

Usefulness of Mapping Biopsy in the Treatment of Penoscrotal Extramammary Paget’s Disease